Sunshine Act/Open Payments Program

The Physician Payments Sunshine Act ("Sunshine Act"), also known as the Open Payments Program, is a law that requires biopharmaceutical companies and other applicable manufacturers to report transfers of value made to physicians and teaching hospitals to the Centers for Medicare & Medicaid Services (CMS) on an annual basis.

The information reported is made available to the public by way of an online searchable database managed by CMS. The Sunshine Act impacts all physicians who have an active US medical license, regardless of specialty.

The types of activities with transfers of values that must be reported include consulting services, meals, honoraria, and research funding and grants. Other interactions where transfers of value also must be reported include informational presentations, speaking engagements, and textbooks, which help educate physicians and allow them to stay current on new treatments, studies and emerging safety information.

For more information, please refer to Takeda Oncology's Ethical Exchange brochure here.